African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5229

Full Length Research Paper

Polymorphisms of the programmed cell death 1 and ICOS genes and kidney transplant rejection in Iranian patients

Padideh Ebadi1*, Mohammad Hossein Karimi2, Mohammad Taher Tahoori3, Bita Geramizadeh2, Jamshid Roozbeh2, Kambiz Bagheri1, Behnam Mohammadi2 and Ali reza Yousefi1
1Biochemistry Department, School of Medicine, Kazerun Branch, Islamic Azad University, Kazerun, Iran. 2Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 3Tarbiat Modares University, Immunology Department, Tehran, Iran.
Email: [email protected]

  •  Accepted: 29 June 2012
  •  Published: 27 October 2012

Abstract

Acute rejection is a common phenomenon in kidney transplantation. Inflammatory and anti inflammatory mediators affect graft microenvironment and its outcome. In this study, we evaluated the role of programmed cell death 1 (PD.1) and ICOS gene polymorphisms in the outcome of kidney transplantation. Polymerase chain reaction -Restriction fragment length polymorphism (PCR-RFLP) method using restriction enzymes was performed to characterize ICOS-693A/G,PD-1.1A/G polymorphisms in 100 kidney transplanted patients. Acute rejection episodes were diagnosed according to standard protocol. Analysis of the results showed that PD.1.1 AA genotype was significantly more frequent (P = 0.0001) in patients with acute rejection and A allele was significantly more frequent (P = 0.006, OR = 0.28, 95% CI = 0.09 - 0.82) in the patients without rejection. ICOS -693 AA genotype and A allele were significantly more frequent (P = 0.03, OR = 4.4, 95% CI = 0.85 - 22.46, P = 0.02, OR = 0.42, 95% CI = 0.19 - 0.96) in rejecting patients, respectively. The present results show that studied gene polymorphisms have predictive values for acute rejection after renal transplantation. Further studies with consideration of different aspects in a larger group of patients would be more elucidative.

 

Key words: Inducible costimulator (ICOS), programmed cell death 1 (PD.1), gene polymorphism.